Since SPRMs affect basic cell programming in hormone-sensitive tissues (not just the uterus) and are known to change endometrial architecture in novel ways, are they associated with an increased risk for cancer SPRMs are now being administered in Europe, so well be paying close attention to outcomes there
You experience persistent fatigue rather than improved energy
Injection site reactions, headache, flushing, water retention, lightheadedness, and increased appetite, among others
This underscores the key issue: a trial powered to identify and confirm efficacy in specific, responsive genetic subsets would be highly complex and require substantial patient numbers to stratify by mutation type
It also helps regulate homocysteine, an amino acid that, when elevated, is associated with cardiovascular and neurological risks
Is BPC-157 prohibited under the WADA Prohibited List